Effect of standardized fluid management on cardiac function after CRS + HIPEC in patients with PMP: a single-center case-control study

References

• Rizvi SA, Syed W, Shergill R. Approach to pseudomyxoma peritonei. World J Gastrointest Surg. 2018;10(5):49–56.
   PubMed Web of Science ®Google Scholar
• Carr NJ, Cecil TD, Mohamed F, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40(1):14–26.
   PubMed Web of Science ®Google Scholar
• Smeenk RM, van Velthuysen ML, Verwaal VJ, et al. Appendiceal neoplasms and pseudomyxoma peritonei: a population-based study. Eur J Surg Oncol. 2008;34(2):196–201.
   PubMed Web of Science ®Google Scholar
• Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017;33(5):511–519.
   PubMed Web of Science ®Google Scholar
• Yang R, Su YD, Ma R, et al. Clinical epidemiology of peritoneal metastases in China: the construction of professional peritoneal metastases treatment centers based on the prevalence rate. Eur J Surg Oncol. 2023;49(1):173–178.
   PubMed Web of Science ®Google Scholar
• Li Y, Xu HB, Peng Z, et al. Expert consensus on cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in the treatment of pseudomyxoma peritonei. Natl Med J Chin. 2019;99(20):1527–1535.
   Google Scholar
• Govaerts K, Lurvink RJ, De Hingh IHJT, et al. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2021;47(1):11–35.
   PubMed Web of Science ®Google Scholar
• Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449–2456.
   PubMed Web of Science ®Google Scholar
• Ansari N, Chandrakumaran K, Dayal S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours. Eur J Surg Oncol. 2016;42(7):1035–1041.
   PubMed Web of Science ®Google Scholar
• Iavazzo C, Spiliotis J. Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Updates Surg. 2020;72(3):923–924.
   PubMed Web of Science ®Google Scholar
• Azzam AZ, Alyahya ZA, Wusaibie AAA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of pseudomyxoma peritonei: a single-center experience. Indian J Gastroenterol. 2017;36(6):452–458.
   PubMedGoogle Scholar
• Delhorme JB, Severac F, Averous G, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin. Br J Surg. 2018;105(6):668–676.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575–1581.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Cytoreductice surgery & perioperative chemotherapy for peritoneal surface malignancy. Woodbury: Cine-Med Inc; 2017. p. 210–211. ISBN 978-1-941805-03-9.
   Google Scholar
• Li Y. Theory and practice in peritoneal surface oncology. Beijing: Scientific and Technical Documentation Press; 2021. p. 173–176. ISBN 978-7-5189-8241-7
   Google Scholar
• Yu Y, Li XB, Lin YL, et al. Efficacy of 1384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Chin J Gastrointest Surg. 2021;24(3):230–239.
   Google Scholar
• Bedi SS, Hetz R, Thomas C, et al. Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. Stem Cells Transl Med. 2013;2(12):953–960.
   PubMed Web of Science ®Google Scholar
• Boesen AK, Maeda Y, Rørbaek Madsen M. Perioperative fluid infusion and its influence on anastomotic leakage after rectal cancer surgery: implications for prevention strategies. Colorectal Dis. 2013;15(9):e522–e527.
   PubMed Web of Science ®Google Scholar
• Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth. 2002;89(4):622–632.
   PubMed Web of Science ®Google Scholar
• Holte K, Kehlet H. Fluid therapy and surgical outcomes in elective surgery: a need for reassessment in fast-track surgery. J Am Coll Surg. 2006;202(6):971–989.
   PubMed Web of Science ®Google Scholar
• Brandstrup B. Fluid therapy for the surgical patient. Best Pract Res Clin Anaesthesiol. 2006;20(2):265–283.
   PubMedGoogle Scholar
• Pearse R, Dawson D, Fawcett J, et al. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised controlled trial [ISRCTN38797445. Crit Care. 2005;9(6):R687–693.
   PubMed Web of Science ®Google Scholar
• Xu C, Peng J, Liu S, et al. Goal-directed fluid therapy versus conventional fluid therapy in colorectal surgery: a meta-analysis of randomized controlled trials. Int J Surg. 2018;56:264–273.
   PubMed Web of Science ®Google Scholar
• Gorgun E, Lan BY, Aydinli HH, et al. Troponin elevation after colorectal surgery: significance and management. Ann Surg. 2016;264(4):605–611.
   PubMed Web of Science ®Google Scholar
• Sarveswaran J, Ikponmwosa A, Asthana S, et al. Should cardiac troponins be used as a risk stratification tool for patients with chronic critical limb ischaemia? Eur J Vasc Endovasc Surg. 2007;33(6):703–707.
   PubMed Web of Science ®Google Scholar
• Nagele P, Brown F, Gage BF, et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. Am Heart J. 2013;166(2):325–332.e1.
   PubMed Web of Science ®Google Scholar
• Weber M, Luchner A, Seeberger M, et al. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur Heart J. 2013;34(11):853–862.
   PubMed Web of Science ®Google Scholar
• Ma J, Xin Q, Wang X, et al. Prediction of perioperative cardiac events through preoperative NT-pro-BNP and cTnI after emergent non-cardiac surgery in elderly patients. PLOS One. 2015;10(3):e0121306.
   PubMed Web of Science ®Google Scholar
• Rodseth RB, Chu R, Lurati Buse GA, et al. Postoperative b-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: systematic review and individual patient meta-analysis. Anesthesiology. 2013;119(2):270–283.
   PubMed Web of Science ®Google Scholar
• Fisher SB, Rafeeq S, Hess K, et al. Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). J Surg Oncol. 2018;117(4):685–691.
   PubMed Web of Science ®Google Scholar